AstraZeneca Plc is to use organ-on-chip technology to test drug compounds for safety and efficacy under a new collaboration with the Boston, Massachusetts, US company Emulate Inc. Emulate will co-locate scientists within AstraZeneca’s laboratories in the UK where the chips will be tested across the AZ pipeline.
